Glaucoma is a group of ocular diseases characterized by damage to the optic nerve that may lead to permanent vision loss. Currently, 76 million people (aged 40-80 years) suffer from glaucoma, and the prevalence is projected to increase to 111.8 million by 2040.1 The diagnosis of glaucoma can be frightening, particularly because there is no known cure. Fortunately, recent advancements in glaucoma surgery have made more options available for patients presenting with new-onset glaucoma. In particular, patients with mild to moderate glaucoma may be eligible for newer minimally invasive glaucoma surgeries (MIGS). This review is both an overview of MIGS, a new class of glaucoma surgeries, and a case study on how one of these novel procedures saved a 47-year-old woman’s vision.
Im, BS, Mose
"GATT: A Micro-invasive Glaucoma Surgery and a Big Step for Glaucoma Treatment,"
inSIGHT: Vol. 2:
1, Article 6.
Available at: https://jdc.jefferson.edu/insight/vol2/iss1/6